Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Runcie

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology|October 1, 1987
Progressive relaxation as a function of procedural variations and anxiety levelR M O'Bannon, H C Rickard, D Runcie
Journal of Experimental Psychology|August 1, 1971
Amnesic effects in short-term memoryN R Ellis, D K Detterman, D Runcie, et al.
Cancers|July 12, 2025
Novel Strategies and Therapeutic Advances for Bladder CancerMatthew I Ehrlich, Robert D Fox, Karie D Runcie, et al.
Current Urology Reports|April 10, 2025
Management of Patients with Muscle-Invasive Bladder Cancer Achieving A Clinical Complete Response after Neoadjuvant Therapy: Evidence and Consideration for Active SurveillanceBenjamin I Joffe, John R Christin, Clémentine Le Coz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 18, 2024
Safety and clinical activity of BMS-986365 (CC-94676), a dual androgen receptor ligand-directed degrader and antagonist, in heavily pretreated patients with metastatic castration-resistant prostate cancerD E Rathkopf, M R Patel, A D Choudhury, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 8, 2026
Corrigendum to "Safety and clinical activity of BMS-986365 (CC-94676), a dual androgen receptor ligand-directed degrader and antagonist, in heavily pretreated patients with metastatic castration-resistant prostate cancer": [Ann Oncol 36 (2025) 76-88]D E Rathkopf, M R Patel, A D Choudhury, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology|October 1, 1987
Progressive relaxation as a function of procedural variations and anxiety levelR M O'Bannon, H C Rickard, D Runcie
Journal of Experimental Psychology|August 1, 1971
Amnesic effects in short-term memoryN R Ellis, D K Detterman, D Runcie, et al.
Cancers|July 12, 2025
Novel Strategies and Therapeutic Advances for Bladder CancerMatthew I Ehrlich, Robert D Fox, Karie D Runcie, et al.
Current Urology Reports|April 10, 2025
Management of Patients with Muscle-Invasive Bladder Cancer Achieving A Clinical Complete Response after Neoadjuvant Therapy: Evidence and Consideration for Active SurveillanceBenjamin I Joffe, John R Christin, Clémentine Le Coz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 18, 2024
Safety and clinical activity of BMS-986365 (CC-94676), a dual androgen receptor ligand-directed degrader and antagonist, in heavily pretreated patients with metastatic castration-resistant prostate cancerD E Rathkopf, M R Patel, A D Choudhury, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 8, 2026
Corrigendum to "Safety and clinical activity of BMS-986365 (CC-94676), a dual androgen receptor ligand-directed degrader and antagonist, in heavily pretreated patients with metastatic castration-resistant prostate cancer": [Ann Oncol 36 (2025) 76-88]D E Rathkopf, M R Patel, A D Choudhury, et al.
Pageof 2